Adzheim Alzheimer’s drug sparks debate over profit and science
The FDA approved Adzheim despite advisory committees concerns about efficacy. Biogen expects about $56,000 per patient yearly, funding uncertainty remains as trials continue. The piece notes high costs, potential access issues, and the need for patient education and transparency while recognizing hopeful potential amid caution.
MENTIONED IN THIS ARTICLE
Food and Drug Administration
FDA
Adzheim
Biogen
CNBC
Aduhelm
Chicago
Daisy Bell
Sunshine
Red River Valley
Clementine
Michael
Can America still do great things
The piece argues long planning, regulatory bloat, and equity politics hinder large projects. It contrasts 1930s bridges and 1989 Bay Bridge repairs with modern delays and rising costs. It cites Greenspan Wooldridge and Kennedy era boldness, urging a return to decisive national uplift.
MENTIONED IN THIS ARTICLE
America
Ashington
Claremont Institute
William Voegels
Voegels
Biden
Washington
Barack Obama
Alan Greenspan
Adrian Wooldridge
United States
Missouri
Ohio
Arkansas
Tennessee
Colorado
Greenspan and
Wooldridge
All America
New York
Boston
George Washington Bridge
Bay Bridge
John Kennedy
Ben Domenech
The
Federalist
Kennedy
Domenech
Democrats Brace for 2022 Midterm Campaign Struggles
The piece outlines how Democrats face tighter voting laws and GOP messaging in 2022. It notes Republican efforts to curb voting access, GOP claims against Democratic policy, and the need for a strong turnout strategy, messaging, and mobilization ahead of the midterms. It cites figures like Rick Scott and references Biden’s handling of COVID and infrastructure.
MENTIONED IN THIS ARTICLE
Ashington
Washington Post
the Post
Elise Wiebeck
Congress
Joe Biden
New York
Alexandria Ocasio-Cortez
Rick Scott
Florida
OnMessage Inc
Scott
Biden
Trump
White House
House
Senate
Also Mentioned on This Page
the Gazette
George Will
New Orleans
U.S
Greenspan and Wooldridge
Greenspan
Union Pacific
New Hampshire
New Jersey
Alaska
Texas
California
Western Union
Fort Laramie
Wyoming
Commodities Exchange
Georgewill
Washpost.com
Stuart Rothenberg
Donald Trump